Marta Vila Ramos

Marta Vila has a degree in pharmacy. She has two masters specialized in Pharmaceutical ndustry and specific discipline in regulatory aspects and pharmacovigilance of medicines. She also completed an Executive MBA at IE as well as a Master in Finance and M&A also at IE. She has worked in companies such as BEXAL, Novartis, Grupo Insud, PwC and Accenture with responsibilities in the areas of strategy and operations. In 2013 she created the services company McH, which he sold 5 years later to Pharmalex Group; She helped the integration as VP of innovation and strategy and in 2020 she created an investment vehicle to support new pharmaceutical ideas.

CORPORATE EXPERIENCE

• Invicta Pharma Investments. Advisor / EY – Parthenon Pharma Committee, 2020 – Present

• Pharmalex. Corporate Development. Vice-president for Business Innovation and Strategy (WW), 2018 – 2020

• McCrowley and Hughes S.L. (McH) Managing Director (Entrepreneur) (EU), 2013 – 2018

• Accenture SPAI (Spain, Portugal, Africa and Israel). Senior Manager, 2010 – 2018

• PricewaterhouseCoopers, S.L Madrid. (Spain), 2009 – 2010

• INSUD Group (Previous Chemo Group). Strategic Planning Manager. EU and Emerging Markets, 2007 – 2009

• Sandoz International. München, Germany (a NOVARTIS Company). Head Pharmacist & Head of Business Development (Portfolio Management). Global, 2006 – 2007

• Sandoz Group. Spain, Madrid (a NOVARTIS Company, after acquisition of HEXAL GmbH) General Manager Reporting and Corporate, 2005 – 2006

• Bexal Farmacéutica, S.A, Madrid (HEXAL), Head of Portfolio Management & Business Development, 1999 – 2005